Document is current
Any future updates will be listed below
-
Authors
Ling, Zhipeng https://orcid.org/0000-0002-3488-1358
Pan, Jun-Ping https://orcid.org/0000-0003-3777-5654
Xiao, Xianglu
Wu, Wenfan
Chen, Guisi https://orcid.org/0009-0003-0921-6019
Shi, Fang https://orcid.org/0009-0000-5106-7262
Chen, Zehuan
Zhang, Haiyi https://orcid.org/0000-0003-4260-1894
Huang, Yuehao
Tang, Qing
Cai, Qiwei
Deng, Shenglong
Niu, Zhangming
Zhang, Shi-Qi https://orcid.org/0000-0001-9751-7652
Wang, He-Ling https://orcid.org/0000-0002-8920-1487
Zhang, Jianying https://orcid.org/0000-0001-8161-7536
Zhou, Xuefeng
Mao, Lipeng https://orcid.org/0000-0002-0629-0307
Li, Junliang
Chen, Hongming
Lu, Guang https://orcid.org/0000-0002-2268-1033
Chen, Guobing https://orcid.org/0000-0002-2401-6168
Fang, Evandro Fei https://orcid.org/0000-0003-0355-7202
Yang, Guang
Wang, Guocai
Xiao, Fei
Zhang, Yubo
- License Information
-
More Information
Article History
Received: 15 April 2026
Accepted: 16 September 2026
First Online: 7 October 2026
Declarations
Declaration of interests: E.F.F. is a co-owner of Fang-S Consultation AS (Organization number 931 410 717) and NO-Age AS (Organization number 933 219 127); he has an MTA with LMITO Therapeutics Inc (South Korea), a CRADA arrangement with ChromaDex (USA), a commercialization agreement with Molecule AG/VITADAO, an MTAs with GeneHarbor (Hong Kong) Biotechnologies Limited, and a data license option agreement with Hong Kong Longevity Science Laboratory (Hong Kong); he is a consultant to MindRank AI (China), NYO3 (Norway), AgeLab (Vitality Nordic AS, Norway), and Hong Kong Longevity Science Laboratory (Hong Kong). X.L.X., W.F.W., Q.W.C., S.L.D. and Z.M.N. are employees to MindRank AI (China). The other authors declare no competing interests.
Competing interests: The authors declare no competing interests.
